Golden
Janssen Pharmaceutica

Janssen Pharmaceutica

Janssen Pharmaceutica is a pharmaceutical company based in Beerse, Belgium and founded in 1953.

Janssen Pharmaceutica develops treatment for patients worldwide in the following therapeutic areas of healthcare: Cardiovascular & Metabolism , Immunology , Infectious Diseases & Vaccines , Neuroscience , Oncology and Pulmonary Hypertension. Janssen partners with academic researchers, governments, patient groups, healthcare professionals, and others in their research. Janssen's activities range from initial basic research and production to commercial and support services and sale of medicines. Janssen Pharmaceutica operates as a subsidiary of Johnson & Johnson.



Timeline

People

Name
Role
LinkedIn

Ai Hua Ong

Company Group Chairman, Asia Pacific



Elizabeth Blackwood

Vice President and Chief Quality Officer, Pharmaceuticals



Elizabeth Forminard

General Counsel, Pharmaceuticals



Jane Griffiths, Ph.D.

Global Head, Actelion



Jeff Steinhorn

Chief Information Officer, Pharmaceuticals, Head of Enterprise Functions, Johnson & Johnson Technology



Jennifer Taubert

Executive Vice President Worldwide Chairman, Pharmaceuticals Johnson & Johnson



Joaquin Duato

Vice Chairman of the Executive Committee Johnson & Johnson



Kris Sterkens

Company Group Chairman, Europe, Middle East, and Africa



Kristen Mulholland

Head of Human Resources, Global, Pharmaceuticals Group and External Innovation



Linda Fedow

Global Lead, Pharmaceutical Communication & Public Affairs



Mathai Mammen, M.D., Ph.D.

Global Head, Research and Development



Patrick Verheyen

Global Head, Janssen Business Development



Paul Stoffels M.D.

Vice Chairman of the Executive Committee, Chief Scientific Officer Johnson & Johnson



Pete Batesko

Vice President, Group Finance, Pharmaceuticals



Remo Colarusso

Vice President, Janssen Supply Chain



Richard Tillyer, Ph.D.

Global Head, Discovery, Product Development & Supply, Jannsen Research & Development



Scott White

Company Group Chairman, North America Pharmaceuticals, Johnson & Johnson



Stef Heylen, M.D.

Chief Operating Officer, Development, Janssen Research & Development



Tom Heyman

Chief Executive Officer



Vanessa Broadhurst

Chief Operating Officer, Development



Further reading

Title
Author
Link
Type
Date
+ Add new row

Documentaries, videos and podcasts

Title
Date
Link
+ Add new row

Companies

Company
CEO
Location
Products/Services
+ Add new row

News

Title
Author
Date
Publisher
Description
January 6, 2020
WebWire
Nominations are now being accepted for the 2020 Dr. Paul Janssen Award for Biomedical Research. This prestigious award celebrates dedicated researchers and champions of science whose basic or clinical discoveries have made, or have the potential to make, significant contributions toward improving human health. Nominations will be accepted until February 29, 2020, at www.pauljanssenaward.com for consideration by an independent selection committee of world-renowned scientists. The winning...
July 16, 2019
WebWire
Johnson & Johnson today announced that it is extending through 2025 global product donations of an intestinal worms treatment made by its Janssen Pharmaceutical Companies. The new five-year expanded commitment will ensure that one billion doses of VERMOX® CHEWABLE (mebendazole chewable 500mg tablets) are provided in the 2021-2025 period to high-burden countries via donations to the World Health Organization (WHO), which manages and coordinates country requests for this valuable medicine. A...

References